Wellnex LifeASX:WNX +9.30% EBITDA Margin % is -3.77% as of Dec. 2025. The stock has 2 warning signs investors should review. Among 1,953 Consumer Packaged Goods companies, Wellnex Life ranks worse than 93.8% on this metric.
EBITDA Margin % is calculated as EBITDA divided by its Revenue. Wellnex Life's EBITDA for the
six
months ended in Dec. 2025 was A$-0.49 Mil. Wellnex Life's Revenue for the
six
months ended in Dec. 2025 was A$12.92 Mil. Therefore, Wellnex Life's EBITDA margin for the quarter that ended in Dec. 2025 was -3.77%.
Wellnex Life (ASX:WNX) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Wellnex Life EBITDA Margin % Related Terms
Wellnex Life EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Wellnex Life's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Packaged Foods subindustry, Wellnex Life's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Wellnex Life EBITDA Margin % vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Wellnex Life's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Wellnex Life's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Wellnex Life (ASX:WNX) has a EBITDA Margin % of -3.77% as of Dec. 2025. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Wellnex Life and its competitors. According to the industry distribution chart, Wellnex Life ranks #1832 out of 1953 companies in the Consumer Packaged Goods industry, placing it in the top 93.8%.
Is Wellnex Life's EBITDA Margin % too high?
Wellnex Life's current EBITDA Margin % is -3.77%. Based on the distribution chart, Wellnex Life ranks #1832 out of 1953 companies in the Consumer Packaged Goods industry, which is in the bottom quartile relative to peers.
How does Wellnex Life's EBITDA Margin % compare to KHC and GIS?
According to the Consumer Packaged Goods industry distribution chart, Wellnex Life ranks #1832 out of 1953 companies for EBITDA Margin %. This places Wellnex Life in the lower half of its industry. The industry median EBITDA Margin % is 8.99. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Consumer Packaged Goods company?
The median EBITDA Margin % among Consumer Packaged Goods companies is 8.99, based on 1,953 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Wellnex Life and its competitors. For the Consumer Packaged Goods industry, the median EBITDA Margin % is 8.99 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Wellnex Life's current EBITDA Margin % is -3.77%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Wellnex Life stock overvalued right now?
Based on GuruFocus' analysis, Wellnex Life (ASX:WNX) is currently considered Possible Value Trap. The stock's GF Value™ is A$0.34, compared to a current price of A$0.05 — trading 86.2% below its estimated fair value. The current EBITDA Margin % is -3.77%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Wellnex Life (ASX:WNX), the current EBITDA Margin % is -3.77% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Wellnex Life Ltd is a consumer healthcare company focused on developing, licensing, marketing, and distributing healthcare and pharmaceutical products. These products are available mainly through Australian retailers and wholesalers, including Coles, Woolworths, Chemist Warehouse, Sigma, and Symbion. The group's offerings include caffeine energy liquid capsules, multivitamins, pain relief creams and sprays, sleep aids, toothpaste, over-the-counter medicines, and medical cannabis products, among others. Its brands include Pharmacy Own, Wellness Life, Mr. Bright, Pain Away, Nighty Night, Wakey Wakey, and Wagner Health Liquigesic. Geographically, the majority of the group's revenue comes from Australia, with additional contributions from the United Kingdom and New Zealand.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:WNX has been successfully added to your 